These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 24412347

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Determination of the critical time point for efficacy of L-arginine infusion therapy in a case of MELAS with frequent stroke-like episodes].
    Sudo A, Sano H, Kawamura N.
    No To Hattatsu; 2014 Jan; 46(1):39-43. PubMed ID: 24620430
    [Abstract] [Full Text] [Related]

  • 23. In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patients.
    Yoneda M, Ikawa M, Arakawa K, Kudo T, Kimura H, Fujibayashi Y, Okazawa H.
    Biochim Biophys Acta; 2012 May; 1820(5):615-8. PubMed ID: 21600268
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Heteroplasmic pathogenic m.12315G>A variant in MT-TL2 presenting with MELAS syndrome and depletion of nitric oxide donors.
    Snyder MT, Manor J, Gijavanekar C, Mizerik E, Kralik SF, Elsea SH, Machol K, Emrick L, Scaglia F.
    Am J Med Genet A; 2024 Mar; 194(3):e63461. PubMed ID: 37953071
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. MR OEF imaging in MELAS.
    Xie S.
    Methods Enzymol; 2014 Mar; 547():433-44. PubMed ID: 25416369
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Reversal of Stroke-Like Episodes With L-Arginine and Meticulous Perioperative Management of Renal Transplantation in a Patient With Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome. Case Report.
    Al Yazidi G, Mulder J, Licht C, Harvey E, Robertson J, Sondheimer N, Tein I.
    Neurohospitalist; 2022 Jan; 12(1):67-73. PubMed ID: 34950389
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.
    Desquiret-Dumas V, Gueguen N, Barth M, Chevrollier A, Hancock S, Wallace DC, Amati-Bonneau P, Henrion D, Bonneau D, Reynier P, Procaccio V.
    Biochim Biophys Acta; 2012 Jun; 1822(6):1019-29. PubMed ID: 22306605
    [Abstract] [Full Text] [Related]

  • 36. The utility of arginine-citrulline stable isotope tracer infusion technique in the assessment of nitric oxide production in MELAS syndrome.
    El-Hattab AW, Jahoor F.
    Int J Cardiol; 2018 Mar 01; 254():282. PubMed ID: 28843720
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [l-arginine efficiency in MELAS syndrome. A case report].
    Moutaouakil F, El Otmani H, Fadel H, Sefrioui F, Slassi I.
    Rev Neurol (Paris); 2009 May 01; 165(5):482-5. PubMed ID: 18849057
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.